Molecular Therapy - Table of Contents alert Volume 24 Issue 7

If you are unable to see the message below, click here to view.

Advertisement Open for Submissions Molecular Therapy - Oncolytics is an online-only, open access journal, focusing on the development and clinical testing of viral, cellular, and other biological therapies targeting cancer. Explore the benefits of submitting your next research article. TABLE OF CONTENTS Volume 24, Issue 7 (August 2016) In this issue Editorial In This Issue Research Highlights Meeting Report Commentary Review Original Articles Also new AOP Editorial Top Expediting Viral Therapies For Cancers To the Clinic Yuman Fong Mol Ther 2016 24: 1161-1162; 10.1038/mt.2016.128 Full Text In This Issue Top In This Issue Mol Ther 2016 24: 1163; 10.1038/mt.2016.129 Full Text Research Highlights Top Research Highlights Mol Ther 2016 24: 1164; 10.1038/mt.2016.130 Full Text Meeting Report Top The Role of Nonhuman Primate Animal Models in the Clinical Development of Pluripotent Stem Cell Therapies So Gun Hong, Yongshun Lin, Cynthia E Dunbar and Jizhong Zou Mol Ther 2016 24: 1165-1169; 10.1038/mt.2016.131 Full Text Commentary Top Socializing Individualized T-Cell Cancer Immunotherapy Richard G Vile Mol Ther 2016 24: 1170-1173; 10.1038/mt.2016.132 Full Text Rethinking the Regulatory Infrastructure for Human Gene Transfer Clinical Trials Christopher L Jenkins, Mark L Bagarazzi, Hans-Peter Kiem, Arnold J Levine, Dale Ando, Carl H June, Tony Reid and David W Emery Mol Ther 2016 24: 1173-1177; 10.1038/mt.2016.133 Full Text Review Top Translational Implications for Off-the-shelf Immune Cells Expressing Chimeric Antigen Receptors Hiroki Torikai and Laurence JN Cooper Mol Ther 2016 24: 1178-1186; advance online publication, May 16, 2016; 10.1038/mt.2016.106 Abstract | Full Text Original Articles Top Safe and Efficient Gene Therapy for Pyruvate Kinase Deficiency Maria Garcia-Gomez, Andrea Calabria, Maria Garcia-Bravo, Fabrizio Benedicenti, Penelope Kosinski, Sergio López-Manzaneda, Collin Hill, María del Mar Mañu-Pereira, Miguel A Martín, Israel Orman, Joan-LLuis Vives-Corrons, Charles Kung, Axel Schambach, Shengfang Jin, Juan A Bueren, Eugenio Montini, Susana Navarro and Jose C Segovia Mol Ther 2016 24: 1187-1198; advance online publication, May 3, 2016; 10.1038/mt.2016.87 Abstract | Full Text CRNDE Promotes Malignant Progression of Glioma by Attenuating miR-384/PIWIL4/STAT3 Axis Jian Zheng, Xiaobai Liu, Ping Wang, Yixue Xue, Jun Ma, Chengbin Qu and Yunhui Liu Mol Ther 2016 24: 1199-1215; advance online publication, April 8, 2016; 10.1038/mt.2016.71 Abstract | Full Text Generation of Genetically Engineered Precursor T-Cells From Human Umbilical Cord Blood Using an Optimized Alpharetroviral Vector Platform Juwita Hübner, Shahabuddin S Hoseini, Julia D Suerth, Dirk Hoffmann, Marcel Maluski, Jessica Herbst, Holger Maul, Arnab Ghosh, Britta Eiz-Vesper, Qinggong Yuan, Michael Ott, Michael Heuser, Axel Schambach and Martin G Sauer Mol Ther 2016 24: 1216-1226; advance online publication, May 3, 2016; 10.1038/mt.2016.89 Abstract | Full Text Rapid and Efficient Stable Gene Transfer to Mesenchymal Stromal Cells Using a Modified Foamy Virus VectorMTOPEN Nathan Paul Sweeney, Cathy Regan, Jiahui Liu, Antonio Galleu, Francesco Dazzi, Dirk Lindemann, Charles Anthony Rupar and Myra Olga McClure Mol Ther 2016 24: 1227-1236; advance online publication, May 2, 2016; 10.1038/mt.2016.91 Abstract | Full Text Development of Third-generation Cocal Envelope Producer Cell Lines for Robust Lentiviral Gene Transfer into Hematopoietic Stem Cells and T-cells Olivier Humbert, Don W. Gisch, Martin E. Wohlfahrt, Amie B. Adams, Phil D. Greenberg, Tom M. Schmitt, Grant D. Trobridge and Hans-Peter Kiem Mol Ther 2016 24: 1237-1246; advance online publication, April 8, 2016; 10.1038/mt.2016.70 Abstract | Full Text In Vivo Selection Yields AAV-B1 Capsid for Central Nervous System and Muscle Gene Therapy Sourav R Choudhury, Zachary Fitzpatrick, Anne F Harris, Stacy A Maitland, Jennifer S Ferreira, Yuanfan Zhang, Shan Ma, Rohit B Sharma, Heather L Gray-Edwards, Jacob A Johnson, Aime K Johnson, Laura C Alonso, Claudio Punzo, Kathryn R Wagner, Casey A Maguire, Robert M Kotin, Douglas R Martin and Miguel Sena-Esteves Mol Ther 2016 24: 1247-1257; advance online publication, April 27, 2016; 10.1038/mt.2016.84 Abstract | Full Text Complete Spectrum of CRISPR/Cas9-induced Mutations on HBV cccDNAMTOPEN Christoph Seeger and Ji A Sohn Mol Ther 2016 24: 1258-1266; advance online publication, May 16, 2016; 10.1038/mt.2016.94 Abstract | Full Text Specific Delivery of MiRNA for High Efficient Inhibition of Prostate Cancer by RNA Nanotechnology Daniel W Binzel, Yi Shu, Hui Li, Meiyan Sun, Qunshu Zhang, Dan Shu, Bin Guo and Peixuan Guo Mol Ther 2016 24: 1267-1277; advance online publication, April 29, 2016; 10.1038/mt.2016.85 Abstract | Full Text Development of Novel Small Hairpin RNAs That do not Require Processing by Dicer or AGO2 Shin-ichiro Ohno, Karen Itano, Yuichirou Harada, Koutaro Asada, Keiki Oikawa, Mikie Kashiwazako, Hikaru Okuyama, Katsuyoshi Kumagai, Masakatsu Takanashi, Katsuko Sudo, Norihiko Ikeda and Masahiko Kuroda Mol Ther 2016 24: 1278-1289; advance online publication, April 25, 2016; 10.1038/mt.2016.81 Abstract | Full Text Mesenchymal Stem Cells Deliver Exogenous MicroRNA-let7c via Exosomes to Attenuate Renal Fibrosis Bo Wang, Kevin Yao, Brooke M Huuskes, Hsin-Hui Shen, Junli Zhuang, Catherine Godson, Eoin P Brennan, Jennifer L Wilkinson-Berka, Andrea F Wise and Sharon D Ricardo Mol Ther 2016 24: 1290-1301; advance online publication, May 18, 2016; 10.1038/mt.2016.90 Abstract | Full Text Analysis of the functional consequences of targeted exon deletion in COL7A1 reveals prospects for dystrophic epidermolysis bullosa therapy Olivier Bornert, Tobias Kühl, Jeroen Bremer, Peter C van den Akker, Anna MG Pasmooij and Alexander Nyström Mol Ther 2016 24: 1302-1311; advance online publication, May 9, 2016; 10.1038/mt.2016.92 Abstract | Full Text Enhanced ADCC and NK Cell Activation of an Anticarcinoma Bispecific Antibody by Genetic Insertion of a Modified IL-15 Cross-linker Joerg U Schmohl, Martin Felices, Elizabeth Taras, Jeff S Miller and Daniel A Vallera Mol Ther 2016 24: 1312-1322; advance online publication, May 9, 2016; 10.1038/mt.2016.88 Abstract | Full Text Predictive and Prognostic Clinical Variables in Cancer Patients Treated With Adenoviral Oncolytic Immunotherapy Kristian Taipale, Ilkka Liikanen, Anniina Koski, Raita Heiskanen, Anna Kanerva, Otto Hemminki, Minna Oksanen, Susanna Grönberg-Vähä-Koskela, Kari Hemminki, Timo Joensuu and Akseli Hemminki Mol Ther 2016 24: 1323-1332; advance online publication, April 4, 2016; 10.1038/mt.2016.67 Abstract | Full Text Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Molecular Therapy. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.